New Drug-releasing Coating for Implants

</a><strong>Background</strong><br>

When repairing a missing, broken or diseased portion of bone, implants are being used fabricated from a variety of materials including metal, polymer and ceramics. To improve the property of implants, a porous coating is typi-cally applied onto the surface to foster long term stabilization. To promote healing, drug substances having e.g. antibiotic, cytostatic and/or osteogenic properties can be coated to the surface of the implant. <br><br> As metal implants are not easily modified to comprise a drug release mecha-nism, the implant coats have been suggested to serve as drug carrier. How-ever, these coatings fail as they are often too mechanically unstable during implant fixation. Furthermore, as the location of the drug on the surface of the implant is determined during the pre-coating process, the pre-coated implants do not allow customization, and loading of the drugs to be delivered. <br><br> <strong>Technology</strong><br> We offer a new elastic biocompatible drug-releasing patch for applica-tion/coating on implants. The drug-delivery patch can be customized in shape, size, and drug loading for optimal local delivery before implantation and applied directly at the operating room.<br><br> <b>Benefits:</b><ul> <li>The coating can be customized specifically for each patient. The customized coating can contain unique drug/dosage combinations specifically for individual patients.</li> <li>Compared to pre-coated prior art implants the new coating provides several advantages including flexibility, ease of use, and point-of care individualization of implants.</li></ul> <p><strong>IP Rights</strong><br> EP application filed 12/2007<br> US application filed 12/2008 <br><br> <strong>Patent Owner</strong><br> Charité – Universitätsmedizin Berlin

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Dr. Dirk Dantz

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Simplified diagnosis of rare eye diseases

Uveitis experts provide an overview of an underestimated imaging technique. Uveitis is a rare inflammatory eye disease. Posterior and panuveitis in particular are associated with a poor prognosis and a…

Targeted use of enfortumab vedotin for the treatment of advanced urothelial carcinoma

New study identifies NECTIN4 amplification as a promising biomarker – Under the leadership of PD Dr. Niklas Klümper, Assistant Physician at the Department of Urology at the University Hospital Bonn…

A novel universal light-based technique

…to control valley polarization in bulk materials. An international team of researchers reports in Nature a new method that achieves valley polarization in centrosymmetric bulk materials in a non-material-specific way…

Partners & Sponsors